Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

N-of-few Study of Pain Perception

NCT04664400
completednot_applicable

Pain, Learning, and Nocebo

NCT04762836
completednot_applicable

Electrophysiological Correlates of Nocebo Effects on Pain

NCT04199858
completednot_applicable

Placebo Effect in the Treatment of Atopic Dermatitis

NCT02094287

Clinical Trials (4)

Showing 4 of 4 trials
NCT04664400Not Applicable

N-of-few Study of Pain Perception

Completed
NCT04762836Not Applicable

Pain, Learning, and Nocebo

Completed
NCT04199858Not Applicable

Electrophysiological Correlates of Nocebo Effects on Pain

Completed
NCT02094287Not Applicable

Placebo Effect in the Treatment of Atopic Dermatitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4